Cargando…

Trends and challenges of multi-drug resistance in childhood tuberculosis

Drug-resistant tuberculosis (DR-TB) in children is a growing global health concern, This review provides an overview of the current epidemiology of childhood TB and DR-TB, including prevalence, incidence, and mortality. We discuss the challenges in diagnosing TB and DR-TB in children and the limitat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Zengfang, Sun, Lin, Song, Xiaorui, Zhu, Hanzhao, Li, Lianju, Zhou, Xintong, Mi, Kaixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275406/ https://www.ncbi.nlm.nih.gov/pubmed/37333849 http://dx.doi.org/10.3389/fcimb.2023.1183590

Ejemplares similares

Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
por: Zhu, Hanzhao, et al.
Publicado: (2023)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022)

The evolving biology of Mycobacterium tuberculosis drug resistance
por: Jones, Richard M., et al.
Publicado: (2022)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
por: Wu, Xiaocui, et al.
Publicado: (2019)

Whole Genome and Transcriptome Sequencing of Two Multi-Drug Resistant Mycobacterium tuberculosis Strains to Facilitate Illustrating Their Virulence in vivo
por: Tang, Jun, et al.
Publicado: (2020)

Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis
por: Poulton, Nicholas C., et al.
Publicado: (2022)

Evolution of Mycobacterium tuberculosis drug resistance in the genomic era
por: Nimmo, Camus, et al.
Publicado: (2022)

Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
por: Liebenberg, Dale, et al.
Publicado: (2022)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis
por: Eoh, Hyungjin, et al.
Publicado: (2022)

Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host
por: Schami, Alyssa, et al.
Publicado: (2023)

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2022)

Detection of differentially culturable tubercle bacteria in sputum from drug-resistant tuberculosis patients
por: Gordhan, Bhavna G., et al.
Publicado: (2022)

Research of childhood tuberculosis in suspected populations by molecular methods: A multicenter study in China
por: Li, Chunling, et al.
Publicado: (2022)

Virome analysis of an ectomycorrhizal fungus Suillus luteus revealing potential evolutionary implications
por: Liu, Hanzhao, et al.
Publicado: (2023)

Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant Salmonella enterica Serovar Typhi
por: Mujawar, Shama, et al.
Publicado: (2018)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance
por: Samuels, Amanda N., et al.
Publicado: (2022)

Editorial: Hot trends in computer-aided drug design techniques
por: Scotti, Luciana, et al.
Publicado: (2023)

Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation
por: Mazzariol, Annarita, et al.
Publicado: (2021)

The M. tuberculosis Rv1523 Methyltransferase Promotes Drug Resistance Through Methylation-Mediated Cell Wall Remodeling and Modulates Macrophages Immune Responses
por: Ali, Sabeeha, et al.
Publicado: (2021)

Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
por: Oh, Sangmi, et al.
Publicado: (2021)

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023)

Challenges of Immune Response Diversity in the Human Population Concerning New Tuberculosis Diagnostics, Therapies, and Vaccines
por: Azad, Abul K., et al.
Publicado: (2020)

The Research Progress in Immunotherapy of Tuberculosis
por: Mi, Jie, et al.
Publicado: (2021)

Reciprocal Cooperation of Type A Procyanidin and Nitrofurantoin Against Multi-Drug Resistant (MDR) UPEC: A pH-Dependent Study
por: Vasudevan, Sahana, et al.
Publicado: (2020)

Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
por: Stanley, Sydney, et al.
Publicado: (2022)

Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular Mycobacterium tuberculosis
por: Rienksma, Rienk A., et al.
Publicado: (2019)

Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design
por: Rudraraju, Reshma S., et al.
Publicado: (2022)

Meta-analysis of active tuberculosis gene expression ascertains host directed drug targets
por: Ponnusamy, Nirmaladevi, et al.
Publicado: (2022)

Editorial: Alternative approaches to antifungal drugs against drug-resistant fungi
por: Kovács, Renátó, et al.
Publicado: (2023)

A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB(®) Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples
por: Bonnet, Isabelle, et al.
Publicado: (2021)

Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis
por: Guo, Qinglong, et al.
Publicado: (2022)

Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
por: Boyd, Natalie K., et al.
Publicado: (2021)

The First Isolation and Molecular Characterization of Shiga Toxin-Producing Virulent Multi-Drug Resistant Atypical Enteropathogenic Escherichia coli O177 Serogroup From South African Cattle
por: Montso, Peter Kotsoana, et al.
Publicado: (2019)

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
por: Peyclit, Lucie, et al.
Publicado: (2019)

HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
por: Khan, Shaheen, et al.
Publicado: (2020)

Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
por: Murphy, Sarah E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aekji6n6tgebrs484ao1lfl8do